Skip to main content
. 2021 Aug 5;12:719602. doi: 10.3389/fphar.2021.719602

FIGURE 3.

FIGURE 3

WEMA slowed OVX-induced bone loss in mice. The mice were orally administered vehicle or WEMA for 5 weeks. (A) µ-CT images, BMD, and bone morphometric parameters of femoral trabecular bone. (B) Body weight gain and uterine weight. OVX, ovariectomy group; WEMA-L, OVX + WEMA 100 mg/kg/day treatment group; WEMA-H, OVX + WEMA 300 mg/kg/day treatment group; BMD, bone mineral density; BV/TV, bone volume per tissue volume; Tb.N, trabecular number; Tb.Th, trabecular thickness. Tb. Sp, trabecular separation; *p < 0.05, **p < 0.01 versus the OVX group.